Catalyst Wire Dossier Catalyst Wire Dossier

Tetrathiomolybdate

tetrathiomolybdate · Memorial Sloan Kettering Cancer Center
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Tetrathiomolybdate, covering 2006-05-09 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Tetrathiomolybdate (TM) Plus Capecitabine [Phase 1, Phase 2]

See pricing